Prostate Cancer Clinical Trials in Philadelphia

Showing 321-339 of 339 trials

Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer

NCT00084526

RATIONALE: New imaging procedures such as CT-on-rails™ may improve the ability to pinpoint the location of the tumor and decrease radiation therapy damage to healthy tissue. PURPOSE: This phase I/II trial is studying how well computed tomography (CT) scans using CT-on-rails™ work in pinpointing the location of the tumor in patients with prostate cancer.

Prostate Cancer

Fox Chase Cancer Center40 participantsStarted Nov 2003

Philadelphia, Pennsylvania, United States

TERMINATEDPhase 2< 1 mile

Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer

NCT00104130

The purpose of this trial is to study KOS-862 in men with metastatic prostate cancer who have failed a docetaxel-containing regimen.

Prostate Cancer

Bristol-Myers Squibb53 participantsStarted Dec 2004

Vallejo, California, United States • Tucker, Georgia, United States • Baltimore, Maryland, United States +6 more locations

COMPLETEDPhase 1/2< 1 mile

Study of Individualized Amonafide to Treat Prostate Cancer

NCT00087854

The purpose of this study is to assess the safety and efficacy of Amonafide in men with androgen-independent prostate cancer, assigned to individualized doses of Amonafide based on acetylator phenotype information (doses adjusted on individual metabolism).

Prostate Cancer

Xanthus Pharmaceuticals, Inc.40 participantsStarted Mar 2004

Los Angeles, California, United States • Baltimore, Maryland, United States • St Louis, Missouri, United States +5 more locations

Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer

Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer

Study of Individualized Amonafide to Treat Prostate Cancer

Prostate Cancer Trials in Other Cities

DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])

Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer

Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer

Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy

A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer

A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer

Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients

Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients

A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer

Mifepristone (RU-486) in Androgen Independent Prostate Cancer

Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy

A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer

(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer

Other Conditions in Philadelphia